Since FOXM1 was inactivated by OTS167 treatment, our results implied that the MELK inhibitor might diminish FOXM1-mediated transcriptional induction of the TOPK gene in SCLC cells. The gene discussed is FOXM1; the disease is small cell lung carcinoma.